- 期刊
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
延伸閱讀
- 黃志富（2022）。Pharmacological Interventions of Non-Alcoholic Fatty Liver Disease。台灣醫學，26(3)，343-348。https://doi.org/10.6320/FJM.202205_26(3).0009
- Velázquez, J. A. L., Córdova, L. D. C., Tapia, N. C. C., Uribe, M., & Sánchez, N. M. (2012). Nuclear Receptors in Nonalcoholic Fatty Liver Disease. Journal of Lipids, 2012(), 5-14. https://doi.org/10.1155/2012/139875
- Ouaamari, A. E., & Minehira, K. (2013). Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications. International Journal of Endocrinology, 2013(), 927-928-212. https://doi.org/10.1155/2013/969748
- 余明隆、高嘉宏（2022）。Special Topic: New Perspectives of Non-Alcoholic Fatty Liver Disease-Introduction。台灣醫學，26(3)，311-312。https://www.airitilibrary.com/Article/Detail?DocID=10281916-202205-202205230003-202205230003-311-312
- Gianni Testino（2009）。Non-alcoholic Fatty Liver Disease and Antiviral Therapy in Hepatitis C。Journal of the Formosan Medical Association，108(3)，262-263。https://www.airitilibrary.com/Article/Detail?DocID=09296646-200903-108-3-262-263-a